Quick answers
- What is Dermatophagoides farinae and dermatophagoides pteronyssinus used for?
- The FDA-approved label (Standardized Mite Dermatophagoides farinae, Greer Laboratories, Inc., February 6, 2025) says: “Greer Standardized Mite ( Dermatophagoides farinae and/or Dermatophagoides pteronyssinus ) Extracts are allergenic extracts indicated for: skin test diagnosis of mite allergy treatment of patients with mite-induced allergic asthma, rhinitis and conjunctivitis. For immunotherapy, patients must show hypersensitivity to Dermatophagoides farinae ( D. farinae ) or Dermatophagoides pteronyssinus ( D. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Dermatophagoides farinae and dermatophagoides pteronyssinus have a boxed warning?
- Yes. The FDA label for Standardized Mite Dermatophagoides farinae has a boxed warning (“WARNING: ANAPHYLAXIS”), the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
- Is there a shortage of Dermatophagoides farinae and dermatophagoides pteronyssinus?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Dermatophagoides farinae and dermatophagoides pteronyssinus been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Dermatophagoides farinae and dermatophagoides pteronyssinus?
- 1 company lists prescription products of Dermatophagoides farinae and dermatophagoides pteronyssinus in the FDA NDC Directory, including Greer Laboratories, Inc..
What Dermatophagoides farinae and dermatophagoides pteronyssinus is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Greer Standardized Mite ( Dermatophagoides farinae and/or Dermatophagoides pteronyssinus ) Extracts are allergenic extracts indicated for: skin test diagnosis of mite allergy treatment of patients with mite-induced allergic asthma, rhinitis and conjunctivitis. For immunotherapy, patients must show hypersensitivity to Dermatophagoides farinae ( D. farinae ) or Dermatophagoides pteronyssinus ( D. …
— FDA label: Standardized Mite Dermatophagoides farinae, Greer Laboratories, Inc., effective February 6, 2025. Read the full label on DailyMed →
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
This label has a boxed warning. Its heading: WARNING: ANAPHYLAXIS
. Read it on the full label →
Forms and how it is given
| Dosage forms | Concentrate |
|---|---|
| Route | Intradermal · Percutaneous · Subcutaneous |
| Prescription products | 1 in the FDA NDC Directory |
| Brand names | Standardized Mite Mix Dermatophagoides Farinae and Dermatophagoides Pteronyssinus |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Greer Laboratories, Inc.1 product
FDA approval history
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| BLA101834 | — | Date not on file | — |
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Standardized Mite Dermatophagoides farinae, Greer Laboratories, Inc., effective February 6, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →